We use cookies to ensure that our site works correctly and provides you with the best experience. If you continue using our site without changing your browser settings, we'll assume that you agree to our use of cookies. Find out more about the cookies we use and how to manage them by reading our cookies policy. Hide

Current Issue

6th December 2010
Selected Chemistry & Industry magazine issue

Select an Issue


C&I e-books

C&I e-books

C&I apps

iOS App
Android App

Computing clean energy Computing clean energy

High performance computing is supercharging research into clean energy solutions.

Read the feature article


oily bird

Digesting a sticky problem

Michael Gross, December 2010

Far too little is known about the microbial communities that may, with the right encouragement, help to clean up oil spills, reports Michael Gross


Top science stories 2010

Cath O'Driscoll, December 2010

From a universal flu vaccine to the world’s first synthetic cell, Cath O’Driscoll presents a snapshot of the chemical science stories making headlines during 2010


Product Focus

Metrohm Product Focus


There are no postcards for the issue of C&I Magazine which you have selected.

Click here to see other postcards from our international correspondents.

International Youth DayAugust 15, 2016


Advanced Materials

Arno Kraft, December 2010

A hybridpolymer–inorganicthermoelectric

Thermoelectric materials are able to convert heat into electricity. All they need is a temperature gradient.


SCI going forward

Joanne Lyall, December 2010

Not content with 130 years of success, the SCI is looking forward to building on its strength as a multidisciplinary forum connecting people across the breadth of the chemicalusing industries and academia, writes Joanne Lyall


Just a step away

Neil Eisberg, December 2010

Personalised medicine is much closer than most of us actually believe, according to a new study from US researchers at Tufts Center for the Study of Drug Development (Tufts CSDD) that is. The study emphasises that the development of personalised medicine is a key strategy for biopharmaceutical companies.


The British contribution

Robert Uhlig, December 2010

Genius of Britain: The scientists who changed the world Robert Uhlig